Cronos To Acquire 4 Redwood Subsidiaries, Expand Growth In US CBD Market

Cronos Group Inc CRON announced Friday it reached an agreement to acquire a CBD company with exposure to the United States.

What Happened

Cronos entered into an agreement to acquire four of Redwood Holding Group's operating subsidiaries, the company said in a press release. Redwood is a maker and distributor of hemp-derived CBD-infused products for the skincare and other segments. The company's products include pure hemp oil that includes natural phytocannabinoids and terpenes found in the plant.

Redwood has exposure to the retail and hospitality space in the U.S. through its own brand called Lord Jones.

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!

Why It's Important

Redwood offers a best-in-class platform with hemp-based CBD formulations that "stand for quality and consistency," Cronos Chairman, President and CEO Mike Gorenstein said in the press release. Under Cronos' umbrella, the company can better address the notable demand for skincare and other consumer products which Redwood addresses.

"The inspiration for our company was simple, we wanted to create a brand we wished we could buy as adult consumers," said Robert Rosenheck, Redwood co-founder. "We chose Cronos Group because they share our vision and values and will help us continue our mission.

As part of the agreement, Cronos will pay around $300 million, net of Redwood's cash and debt of which $225 million will be paid in cash with the rest in newly issued Cronos stock. The deal remains subject to customary closing conditions and regulatory approvals and is expected to close in the third quarter of 2019.

Shares of Cronos traded higher by 4% at $13.25 in Friday's pre-market session.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisM&ANewsMarketscannabinoidCBDMike Gorenstein
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.


Loading...